This topic contains a solution. Click here to go to the answer

Author Question: Patients with chronic renal insufficiency develop anemia because their kidneys synthesize inadequate ... (Read 93 times)

wrbasek0

  • Hero Member
  • *****
  • Posts: 560
Patients with chronic renal insufficiency develop anemia because their kidneys synthesize inadequate amounts of:
 
  a. hemoglobin.
  b. erythropoietin.
  c. vitamin B12.
  d. bioavailable iron.

Question 2

In young adults with chronic renal disease, daily energy intake should be:
 
  a. 30 kcal/kg.
  b. 35 kcal/kg.
  c. 40 kcal/kg.
  d. 45 kcal/kg.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yasmina

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

B

Answer to Question 2

B




wrbasek0

  • Member
  • Posts: 560
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library